Clinical trials for developing new therapeutic and preventive treatments for Alzheimer's disease are often costly, complicated and sometimes not possible to carry out with old individuals with less mobility and significant medical issues. The study published in the journal Alzheimer's & Dementia showed the results of a novel four-year, randomized clinical trial evaluating different home-based methods to assess cognitive function and decline in participants over 75 years of age.
Almost 600 persons participated in the home-based assessment (HBA) study; all had been previously diagnosed as either possessing normal cognitive abilities or suffering from Mild Cognitive Impairment, a condition that often precedes AD.
Alzheimers Disease
Alzheimer''s disease is a progressive neurodegenerative disease affecting memory and thinking and making the person increasingly dependent on others.
Advertisement
‘The results of the study proved that human interaction is integral to successful clinical trials.’
Tweet it Now
The HBA study evaluated three different methods for monitoring and measuring cognitive function, particularly as participants progressed from normal abilities to impairment and dementia. There were three primary objectives: 1. Establish feasibility and efficiency of the three home-based assessment methods; 2. Determine how home-based assessments captured cognitive change over time; and 3. Evaluate participants' adherence in taking prescribed medication as a performance-based assessment of functional ability.
"We wanted to know if we could remotely assess cognition and other outcomes using various types of technology," said first author Mary Sano, PhD, professor of psychiatry and director of the Alzheimer's Disease Research Center at the Icahn School of Medicine at Mount Sinai in New York City. "We needed to know this because prevention of dementia studies are long and assessing people in their home may reduce the burden of traveling to medical centers for study participants."
![Genetics of Alzheimer´s disease]( "Genetics of Alzheimer´s disease")
There are numerous genes that have been discovered that are associated with Alzheimer's disease and indicate increased risk, aiding genetic counseling and better care.
Researchers also wanted to determine if home-based assessments would improve participant retention rates, lower study costs and create a more robust representation of varied study participants.
The assessment methods used were mail-in questionnaires with live telephone interviews; automated telephone calls with an interactive voice-response system; and computer-based assessments with internet connectivity, using a kiosk interface installed at the participants homes. Cognitive and functional tests were employed using all three assessment methods.
Feasibility was measured by the ability to recruit, screen, enroll and retain participants. Efficiency was measured by the number of site staff contacts and amount of site staff time required to complete assessments.
The team found that all three approaches were feasible, but with modestly different degrees of success. Dropout rates were low and similar across technologies, though participants who had kiosk tools installed in their homes were more likely to dropout earlier.
Staff resources were also higher for the kiosk group. All of the in-home instruments were able to distinguish between neurologically stable participants and those experiencing cognitive decline. Internet-based assessments were less efficient compared to testing by live assessors.
Overall, researchers said the results were broadly encouraging, and worth further investigation and development.
"This study taught us how to engage a diverse community of very elderly subjects with a mean age over 80 years in web-based data collection, as well as in traditional testing methods over multiple years," Sano said.
By providing the tools and the access to all technologies, the study was also able to engage a large group of minority participants, demonstrating that participation is possible when resources are provided.
Howard Feldman, MD, director of ADCS and professor of neurosciences at UC San Diego School of Medicine, said the HBA study sets in motion multiple possibilities.
"We are always looking at ways to improve cognitive assessments by the most effective and expedient means possible. If we can make participating in clinical research easier on participants, through tools they are comfortable using, everyone benefits. This study is another reminder that human interaction is an important part of successful clinical trials."
Source: Newswise
Genetics of Alzheimer´s disease
There are numerous genes that have been discovered that are associated with Alzheimer's disease and indicate increased risk, aiding genetic counseling and better care.
Advertisement
Researchers also wanted to determine if home-based assessments would improve participant retention rates, lower study costs and create a more robust representation of varied study participants.
The assessment methods used were mail-in questionnaires with live telephone interviews; automated telephone calls with an interactive voice-response system; and computer-based assessments with internet connectivity, using a kiosk interface installed at the participants homes. Cognitive and functional tests were employed using all three assessment methods.
Feasibility was measured by the ability to recruit, screen, enroll and retain participants. Efficiency was measured by the number of site staff contacts and amount of site staff time required to complete assessments.
The team found that all three approaches were feasible, but with modestly different degrees of success. Dropout rates were low and similar across technologies, though participants who had kiosk tools installed in their homes were more likely to dropout earlier.
Staff resources were also higher for the kiosk group. All of the in-home instruments were able to distinguish between neurologically stable participants and those experiencing cognitive decline. Internet-based assessments were less efficient compared to testing by live assessors.
Overall, researchers said the results were broadly encouraging, and worth further investigation and development.
"This study taught us how to engage a diverse community of very elderly subjects with a mean age over 80 years in web-based data collection, as well as in traditional testing methods over multiple years," Sano said.
By providing the tools and the access to all technologies, the study was also able to engage a large group of minority participants, demonstrating that participation is possible when resources are provided.
Howard Feldman, MD, director of ADCS and professor of neurosciences at UC San Diego School of Medicine, said the HBA study sets in motion multiple possibilities.
"We are always looking at ways to improve cognitive assessments by the most effective and expedient means possible. If we can make participating in clinical research easier on participants, through tools they are comfortable using, everyone benefits. This study is another reminder that human interaction is an important part of successful clinical trials."
Source: Newswise
Diet and Alzheimer´s Disease
Alzheimer''s begins with forgetfulness, but over time affects speech and coordination along with drastic behavioral changes. The right diet may lower your risk by 40%. So isn''t a diet change worth it?
Advertisement
 Diseases Related to Old AgeAgeing is referred to the accumulation of changes that brings a person closer to death. | Advertisement
|
Advertisement
Recommended Reading
Latest Clinical Trials News
Is there a new way to treat lymphedema? Yes, swelling due to damaged lymphatic vessels can be treated using nanoparticles that can travel through the lymphatic vessels.
Early and late Chronic Traumatic Encephalopathy (CTE) disease processes in the post-mortem brains were similar in some ways but dramatically different in others.
Researchers have developed a new hydrogel biomaterial that adheres to heart tissue to prevent scar tissue formation after a heart attack and its consequences.
The oil extracted from Cannabidiol (CBD) present in cannabis (marijuana) does not lower pain scores after common treatment for urinary stones.
A clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy adults found it prompted immune response and was safe.